477 related articles for article (PubMed ID: 22990306)
1. Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study.
Michaud DS; Izard J; Wilhelm-Benartzi CS; You DH; Grote VA; Tjønneland A; Dahm CC; Overvad K; Jenab M; Fedirko V; Boutron-Ruault MC; Clavel-Chapelon F; Racine A; Kaaks R; Boeing H; Foerster J; Trichopoulou A; Lagiou P; Trichopoulos D; Sacerdote C; Sieri S; Palli D; Tumino R; Panico S; Siersema PD; Peeters PH; Lund E; Barricarte A; Huerta JM; Molina-Montes E; Dorronsoro M; Quirós JR; Duell EJ; Ye W; Sund M; Lindkvist B; Johansen D; Khaw KT; Wareham N; Travis RC; Vineis P; Bueno-de-Mesquita HB; Riboli E
Gut; 2013 Dec; 62(12):1764-70. PubMed ID: 22990306
[TBL] [Abstract][Full Text] [Related]
2. Porphyromonas gingivalis antibody levels and diagnosis of coronary artery disease in HIV-positive individuals.
Berquist VL; Hearps AC; Ford P; Jaworowski A; Leishman SJ; Hoy JF; Trevillyan JM
J Periodontal Res; 2017 Oct; 52(5):930-935. PubMed ID: 28397248
[TBL] [Abstract][Full Text] [Related]
3. Relationship between past myocardial infarction, periodontal disease and Porphyromonas gingivalis serum antibodies: A case-control study.
Łysek RP; Szafraniec K; Polak M; Jankowski P; Micek A; Wolfshaut-Wolak R; Czarnecka D; Potempa J; Pająk A
Cardiol J; 2018; 25(3):386-392. PubMed ID: 28151544
[TBL] [Abstract][Full Text] [Related]
4. Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study.
Fan X; Alekseyenko AV; Wu J; Peters BA; Jacobs EJ; Gapstur SM; Purdue MP; Abnet CC; Stolzenberg-Solomon R; Miller G; Ravel J; Hayes RB; Ahn J
Gut; 2018 Jan; 67(1):120-127. PubMed ID: 27742762
[TBL] [Abstract][Full Text] [Related]
5. Smoking and periodontal disease: discrimination of antibody responses to pathogenic and commensal oral bacteria.
Hayman L; Steffen MJ; Stevens J; Badger E; Tempro P; Fuller B; McGuire A; Al-Sabbagh M; Thomas MV; Ebersole JL
Clin Exp Immunol; 2011 Apr; 164(1):118-26. PubMed ID: 21303363
[TBL] [Abstract][Full Text] [Related]
6. Oral Health and the Oral Microbiome in Pancreatic Cancer: An Overview of Epidemiological Studies.
Bracci PM
Cancer J; 2017; 23(6):310-314. PubMed ID: 29189325
[TBL] [Abstract][Full Text] [Related]
7. Subgingival microflora and antibody responses against periodontal bacteria of young Japanese patients with type 1 diabetes mellitus.
Takahashi K; Nishimura F; Kurihara M; Iwamoto Y; Takashiba S; Miyata T; Murayama Y
J Int Acad Periodontol; 2001 Oct; 3(4):104-11. PubMed ID: 12666949
[TBL] [Abstract][Full Text] [Related]
8. Serum antibody to Porphyromonas gingivalis in metabolic syndrome among an older Japanese population.
Iwasaki M; Minagawa K; Sato M; Kaneko N; Imai S; Yoshihara A; Miyazaki H
Gerodontology; 2016 Jun; 33(2):193-200. PubMed ID: 24924482
[TBL] [Abstract][Full Text] [Related]
9. Smoking-related cotinine levels and host responses in chronic periodontitis.
Ebersole JL; Steffen MJ; Thomas MV; Al-Sabbagh M
J Periodontal Res; 2014 Oct; 49(5):642-51. PubMed ID: 24283398
[TBL] [Abstract][Full Text] [Related]
10. Serum IgG antibody response to periodontal pathogens in minority populations: relationship to periodontal disease status and progression.
Craig RG; Boylan R; Yip J; Mijares D; Imam M; Socransky SS; Taubman MA; Haffajee AD
J Periodontal Res; 2002 Apr; 37(2):132-46. PubMed ID: 12009183
[TBL] [Abstract][Full Text] [Related]
11. Serum antibodies to periodontal pathogens and markers of systemic inflammation.
Dye BA; Choudhary K; Shea S; Papapanou PN
J Clin Periodontol; 2005 Dec; 32(12):1189-99. PubMed ID: 16268994
[TBL] [Abstract][Full Text] [Related]
12. "Checkerboard" assessments of periodontal microbiota and serum antibody responses: a case-control study.
Papapanou PN; Neiderud AM; Papadimitriou A; Sandros J; Dahlén G
J Periodontol; 2000 Jun; 71(6):885-97. PubMed ID: 10914791
[TBL] [Abstract][Full Text] [Related]
13. Relationship between serologic markers of periodontal bacteria and metabolic syndrome and its components.
Shrestha D; Choi YH; Zhang J; Hazlett LJ; Merchant AT
J Periodontol; 2015 Mar; 86(3):418-30. PubMed ID: 25415246
[TBL] [Abstract][Full Text] [Related]
14. Associations of periodontal status with general health conditions and serum antibody titers for Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans.
Furuichi Y; Shimotsu A; Ito H; Namariyama Y; Yotsumoto Y; Hino Y; Mishige Y; Inoue M; Izumi Y
J Periodontol; 2003 Oct; 74(10):1491-7. PubMed ID: 14653396
[TBL] [Abstract][Full Text] [Related]
15. Differences in immune response to Porphyromonas gingivalis.
Tebloeva LM; Revazova ZE; Fabrikant KG; Dmitrieva LA; Gurevich KG
J Contemp Dent Pract; 2014 Sep; 15(5):573-5. PubMed ID: 25707828
[TBL] [Abstract][Full Text] [Related]
16. Study Links Periodontal Disease Bacteria to Pancreatic Cancer Risk.
Jacob JA
JAMA; 2016 Jun; 315(24):2653-4. PubMed ID: 27244554
[No Abstract] [Full Text] [Related]
17. Serum antibodies to periodontal pathogens are a risk factor for Alzheimer's disease.
Sparks Stein P; Steffen MJ; Smith C; Jicha G; Ebersole JL; Abner E; Dawson D
Alzheimers Dement; 2012 May; 8(3):196-203. PubMed ID: 22546352
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1alpha stimulation in monocytes by periodontal bacteria: antagonistic effects of Porphyromonas gingivalis.
Bostanci N; Allaker R; Johansson U; Rangarajan M; Curtis MA; Hughes FJ; McKay IJ
Oral Microbiol Immunol; 2007 Feb; 22(1):52-60. PubMed ID: 17241171
[TBL] [Abstract][Full Text] [Related]
19. Elevated antibody titers to Porphyromonas gingivalis as a possible predictor of ischemic vascular disease - results from the Tokamachi-Nakasato cohort study.
Tabeta K; Tanabe N; Yonezawa D; Miyashita H; Maekawa T; Takahashi N; Okui T; Nakajima T; Yamazaki K
J Atheroscler Thromb; 2011; 18(9):808-17. PubMed ID: 21670558
[TBL] [Abstract][Full Text] [Related]
20. Characterization of T lymphocyte clones derived from Porphyromonas gingivalis infected subjects.
Gemmell E; Woodford V; Seymour GJ
J Periodontal Res; 1996 Jan; 31(1):47-56. PubMed ID: 8636876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
